CRST Oy - Clinical Research Services Turku

Turku, Southwest Finland 20520

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer

Studies at this site

• A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) — Running, not enrolling